Category Archives: US Pressure

US turns screws on India over patent laws

By Nayanima Basu, The Hindu BusinessLine  | JUNE 27, 2017 India’s Intellectual Property Rights (IPR) and patent law enforcement as well New Delhi’s decision to cap prices of medical devices remained a contentious issue with the US even during Prime Minister … Continue reading

Posted in IPR, Patent, Uncategorized, US Pressure | 1 Comment

Many issues on tap for Trump-Modi visit

Source: Politico | June 26, 2017 TRUMP’S CHANCE TO RESET THE INDIA TRADE RELATIONSHIP: Indian Prime Minister Narendra Modi is meeting with President Donald Trump at the White House today, where they are expected to broach a wide-range of issues, … Continue reading

Posted in IPR, Uncategorized, US Pressure | Leave a comment

The Trump Executive Order on drug prices: not what was promised nor needed, and contrary to US self interest

Source: Medium Emily Kopp has a big scoop for Kaiser Health News. She has obtained a six page document outlining the draft provisions or objectives of a proposed Presidential Executive Order (EO) on drug prices. She has shared some of … Continue reading

Posted in Compulsory Licensing, Data Exclusivity, Evergreening, IPR Enforcement, Special 301 report, Uncategorized, UNHLP report, US Pressure | Leave a comment

June 2017 Alert: Pressure on countries hiked by US on IP

The US government is stepping up on TRIPS plus pressure through bilateral forums based on a US law that passed under Obama to strengthen IPR enforcement and the 301 process. Countries targeted include India, Indonesia, China, Thailand, Ukraine in Asia … Continue reading

Posted in Compulsory Licensing, Data Exclusivity, Evergreening, IPR Enforcement, Special 301 report, Uncategorized, UNHLP report, US Pressure | Leave a comment